Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |